Cookies on the Business Insider India website

Business Insider India has updated its Privacy and Cookie policy. We use cookies to ensure that we give you the better experience on our website. If you continue without changing your settings, we\'ll assume that you are happy to receive all cookies on the Business Insider India website. However, you can change your cookie setting at any time by clicking on our Cookie Policy at any time. You can also see our Privacy Policy.

It looks like a key Valeant deal might be falling apart, and now the stock is tanking

Rachael LevyNov 30, 2016, 20:53 IST

Valeant CEO Joe PapaReuters

Valeant's stock is tanking after Dow Jones reported that talks to sell its Salix unit to Takeda have broken down.

Valeant's stock fell as much as 6% this morning.

The embattled pharma company had been in talks to sell the unit to Japan's Takeda for $10 billion.

The stock jumped up the stock 30% on the news.

This is a developing story. More to follow.

NOW WATCH: Richard Branson: Entrepreneurs need to fill the gap where government is lacking

Please enable Javascript to watch this video